This inventor holds 1 USPTO granted patent. Top assignee: Pfenex Inc.. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: The Innovations of Philip P. Dao
Introduction
Philip P. Dao is a notable inventor based in Lausanne, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of vaccines. His work focuses on optimizing synthetic polynucleotides, which play a crucial role in vaccine efficacy.
Latest Patents
Philip P. Dao holds a patent for "RPA optimization," which involves an optimized synthetic polynucleotide encoding a protective antigen and an anthrax vaccine based on the encoded protective antigen. This innovation also includes the heterologous expression in host bacteria of an optimized polynucleotide sequence encoding a protective antigen. This patent highlights his commitment to advancing vaccine technology.
Career Highlights
Dao is currently associated with Pfenex Inc., a company known for its innovative approaches in biopharmaceutical development. His work at Pfenex has allowed him to explore new avenues in vaccine research and development, contributing to the company's mission of improving public health.
Collaborations
Philip P. Dao has collaborated with notable colleagues, including Lada Rasochova and Jamie P. Phelps. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Philip P. Dao's contributions to vaccine technology through his innovative patents and collaborations underscore his importance in the field of biotechnology. His work continues to pave the way for advancements in public health and vaccine development.